Professor Mark Kendall is working on the development of the needle-free ‘Nanopatch’, to revolutionise delivery of vaccines in the developing world making them cheaper and potentially saving the lives of the millions of people who die from infectious diseases.
The number of people suffering from influenza in Australia this year has soared compared to recorded numbers from previous years, with nearly 8,000 cases so far compared to about 2,000 last year.
23 June 2011 – The US Food & Drug Administration (FDA) has just issued a warning letter about the safety of CSL’s influenza vaccine, Fluvax. The letter follows FDA’s latest annual inspection of CSL laboratories and lays out five “objectionable conditions” in which the company has failed to comply with good manufacturing practice.
Today the Gillard Government released an independent assessment of Australia’s management of vaccine adverse events. Commissioned by the Parliamentary Secretary for Health & Ageing, Catherine King, the review was conducted by former Chief Medical Officer, Professor John Horvath AO.